Thursday, December 31, 2009

PSA - Benefits of Vitamin C . . . (Part Two)

******
******

Vitamin C Not As Effective After Chemotherapy Has Been Used


Vitamin C and cancer: Linus Pauling is considered the pioneer in the use of oral and intravenous vitamin c in the treatment of cancer. His documented studies in extending cancer survival using large doses of Vitamin C are seen as a benchmark by all those who seek to replicate or refute the beneficial claims of Vitamin C.

In 1979, the Mayo Clinic undertook a clinical study to replicate or refute the earlier studies of Linus Pauling. The study participants (with a few exceptions) had all received chemotherapy PRIOR to being given ORAL doses of Vitamin C. The study concluded by the Mayo Clinic reported no evidence that large doses of Vitamin C help in extending cancer survival.

The following is a letter from Linus Pauling to the Editor of The Times Magazine who reported "Vitamin C Fails as a Cancer Cure" as a result of the Mayo Clinic findings.

By Linus Pauling (October 24, 1979)
[ http://profiles.nlm.nih.gov/MM/B/B/R/R/_/mmbbrr.pdf ]

To the Editor: An article in your Sept. 30 Week in Review section, "Vitamin C Fails as a Cancer Cure" (with reference to me in the first sentence), said that a controlled study of 150 Mayo Clinic patients with advanced cancer, published in the New England Journal of Medicine, had shown no evidence that large doses of vitamin C help.

This is indeed what was reported by the Mayo Clinic investigators. They themselves and The Times article do not point out, however, that the population of cancer patients investigated in the Mayo Clinic was so different from that investigated by my associate Dr. Ewan Cameron in Vale of Leven Hospital, Loch Lomondside, Scotland, that the results observed in the Mayo Clinic study cannot be considered to refute the results observed in the study in Scotland.

The chief investigator in the Mayo Clinic study wrote to me last year that he hoped to repeat Dr. Cameron's work as closely as possible. I then wrote to him, pointing out that cyto-toxic chemotherapy damages the body's protective mechanisms to such an extent that subsequent treatment with Vitamin C would not be expected to have much value, because Vitamin C functions largely by potentiating these protective mechanisms.

I recommended strongly that only patients who had not received chemotherapy be used in the Mayo Clinic study. This recommendation, however, was ignored. Nearly all the patients in the Mayo Clinic trial had received courses of chemotherapy, whereas only 4 percent of those studied by Dr. Cameron had receieved chemotherapy.

The Vale of Leven study showed that large doses of Vitamin C have great value for cancer patients who have NOT received chemotherapy. The Mayo Clinic study answers an important question in that it verifies that treatment with Vitamin C is far less effective for patients whose immune systems have been damaged by courses of chemotherapy.

PSA: Scientists find turmeric and black pepper spices may prevent breast cancer

******
******
Scientists find turmeric and black pepper spices may prevent breast cancer

(NaturalNews) Seasoning food with turmeric and black pepper can do more than just spice up a meal. Researchers at the University of Michigan (U-M) Comprehensive Cancer Center have found that the compounds curcumin, which is derived from turmeric, and piperine, derived from black pepper, could play an important role in preventing and even treating breast cancer.

Previous research has already provided evidence that curcumin and piperine may be potential cancer treatments. However, the new U-M study, just published online in the journal Breast Cancer Research and Treatment, is the first to suggest exactly how these natural spice compounds could prevent cancer. The research shows curcumin and piperine target stem cells (unspecialized cells that can give rise to any type of cell in an organ). This is of major significance because cancer stem cells comprise the small number of cells inside a tumor that fuel the growth of malignancies.

Current chemotherapy agents are useless against these cells -- that's why cancer can recur and spread despite rounds of heavy duty, toxic chemo. But if cancer stem cells could be eliminated and/or their growth shut down, cancer should be controlled.

"If we can limit the number of stem cells, we can limit the number of cells with potential to form tumors," lead author Madhuri Kakarala, M.D., Ph.D., a clinical lecturer in internal medicine at the U-M Medical School and a research investigator at the VA Ann Arbor Healthcare System, said in a statement to the media. And the new study shows curcumin and piperine work along these lines. The spice derivatives are able to do what chemo can't -- they limit the self-renewal of stem cells.
Killing cancer cells with zero toxicity to healthy cells
For the U-M study, the research team applied a solution of curcumin and piperine to cell cultures at the equivalent of about 20 times the potency of what a person would take in through diet. Then a series of tests were performed on the cells to look at markers for breast stem cells and the effect curcumin and piperine had on the levels of stem cells.

The result? Piperine enhanced the effects of curcumin and the compounds interrupted the self-renewal process that is the hallmark of stem cells which initiate cancer. More good news: the compounds had no effect on the normal process of cell development known as cell differentiation. That means the spice compounds are not toxic to normal breast tissue.

"Women at high risk of breast cancer right now can choose to take the drugs tamoxifen or raloxifene for prevention, but most women won't take these drugs because there is too much toxicity. The concept that dietary compounds can help is attractive, and curcumin and piperine appear to have very low toxicity," Dr. Kakarala stated.

In addition, tamoxifen and raloxifene are designed to target estrogen. But not all breast cancers are estrogen driven. In fact, the most aggressive and deadly forms of breast cancer that are more likely to occur in women with strong family histories of the disease or with a specific genetic susceptibility to breast cancer are typically not affected by estrogen and tend to be difficult to treat. But due to the fact curcumin and piperine limit the self-renewal of stem cells, the spice compounds could impact malignancies whether they are estrogen sensitive or not.

Dr. Kakarala and colleagues are moving forward on an initial Phase 1 clinical trial in people to determine the best tolerated dose of curcumin and piperine. The study is expected to start signing on volunteer research subjects in spring of 2010.

For more information:
http://www2.med.umich.edu/prmc/medi...

TCS Post Script: I first came across the potential benefits of Turmeric (aka curcumin) when reading Suzanne Somers book Knockout (btw, an easy read if you overlook the lack of literary style - and read with a sceptical eye. I am not ready to sign up for vaginal injections or coffee enemas just yet!) I was intrigued by the assertions made regarding turmeric and did a little more investigation. Ingesting is no harm no foul so I have included turmeric into my daily supplement regimen...in addition to being a little more liberal with it in my cooking. As far as pepper: fresh ground has ALWAYS been a fav spice of mine. Since I ended up on this path, I guess that staple, alone, was not enough to stave off my breast cancer.

Wednesday, December 30, 2009

PSA - Benefits of Vitamin C . . . (First Installment)

******
******

High Dose Vitamin C and Cancer - What It Does

High doses of Vitamin C can be taken orally or intravenously. High doses - oral or intravenous vitamin c - have a negative effect on cancer cell growth. Vitamin C also enhances the immune system by increased lymphocyte production, walls off tumors by stimulating collagen formation, prevents metastasis, expedites wound healing after cancer surgery, neutralizes carcinogenic substances and prevents cellular free radical damage. High dose - oral or intravenous vitamin c - also has an ameliorating effect on the side effects of the highly oxidative chemotherapeutic agents. Some of the side effects of chemotherapy are so severe that many patients stop therapy as a result. It has been shown to increase the lifespan of some cancer patients when receiving 10 100 grams 2-7 times per week of vitamin c – more notably when chemotherapy has not already been used.

High Dose - oral or intravenous vitamin C - inhibits hyaluronidase, an enzyme that tumors use to metastasize and invade other organs throughout the body. It induces apoptosis to help program cancer cells into dying early. It corrects the almost universal scurvy in cancer patients. Cancer patients undergoing conventional adjuvant treatments are normally tired, listless, bruise easily and have a poor appetite. They don't sleep well and have a low threshold for pain. This adds up to a very classic picture of scurvy that generally goes unrecognized by conventional physicians.

When cancer patients receive high doses - oral or intravenous vitamin C - they report that their pain level goes down, and that they are better able to tolerate their chemotherapy. They bounce back quicker since the high dose Vitamin C reduces the toxicity of the chemotherapy and radiation without compromising their cancer cell killing effects. High Dose - oral or intravenous vitamin c - is complementary to oncologic care. It is not "either/or" - it's a good "both/and" proposition. High Dose - oral or intravenous vitamin c can help cancer patients withstand the effects of their traditional therapies, heal faster, be more resilient to infection, develop a better appetite, and remain more active overall. These things promote a better response to cancer therapy.

http://www.orthomolecular.org/history/hoffer/index.shtml


TC Post Script: I have chosen not to do either chemotherapy or radiation. I have, however, been on a regimen of 60 grams of IV Vitamin C weekly since my mastectomy; and I orally ingest 3000 mgs of Vitamin C supplements daily.

Friday, December 18, 2009

PSA - Alcohol & Breast Cancer Recurrence

******
******

Alcohol Raises Risk of Breast Cancer Recurrence

Study Shows Drinking More Than 3 Drinks a Week Is Linked to Return of Cancer

Dec. 10, 2009 (San Antonio) -- If you've been diagnosed with breast cancer, you may want to cut down on alcoholic beverages.

That's the suggestion of researchers who found that cancer is 34% more likely to come back in breast cancer survivors who drink more than three drinks a week, compared with those who abstain or drink less.

Drinking more than three drinks a week also raised the risk of dying from breast cancer by 51%, says Marilyn L. Kwan, PhD, a staff scientist at Kaiser Permanente in Oakland, Calif.

"Women with breast cancer who are postmenopausal or overweight seem to be most susceptible to the effects of alcohol." The findings were presented at the San Antonio Breast Cancer Symposium.

Previous research has linked alcohol to an increased risk of developing breast cancer, but little is known about alcohol's effect on women who have already been diagnosed with the disease.

So Kwan and colleagues followed 1,897 women who had been successfully treated for early-stage breast cancer between 1997 and 2000. About a year after diagnosis, they were asked whether they drank alcohol, how much they drank, and their drink of choice.

Over the next eight years, 349 of the women suffered a recurrence of their breast cancer, and 332 died of the disease.

"We don't think the type of alcohol mattered, but it was difficult to examine since 90% of the women in our study drank wine," Kwan says. But how much they drank did matter; women who indulged in two or more glasses of wine per day were most likely to suffer a recurrence, she says.

It makes sense that alcohol would raise both the risk of developing breast cancer and the chance that it will come back, Kwan says. "Alcohol increases levels of estrogen in the body, and breast cancer is fueled by estrogen."

Jeffrey Peppercorn, MD, a breast cancer specialist at Duke University, states that women who are diagnosed with breast cancer often want to know what they can do to lower their risk of recurrence.

"Limiting alcohol consumption is one step they can take," he says. "I tell women we're not sure that any amount of alcohol is safe ... but that it would be prudent to limit consumption except on rare, special occasions."


TC Post Script: Over the last 25 years (i.e., post undergrad studies), my alcohol consumption has been limited to the occassional Cosmo and 1.5 glasses of red wine on a Friday or Saturday night. (Yeah...PARTY ANIMAL!!!) I have also maintained a consistent body weight of 100-104 lbs (except during pregnancies). So...for me, more information on the unknown.

Thursday, December 17, 2009

Rabbit Holes that Lead to Yellow Brick Roads, that Lead to OZ?: PART II

******
******
If I had not been in a public coffee house I think I would have had my second cry since this odyssey began.

Dr. Isaacs' office did call -- four hours later. The
Great Oz deigned to offer me an audience. Yipee Skipee!

"Make sure you bring a CD of your PetScan. He will look at films too, but prefers a CD."

Of course he does . . .

. . . .to be continued


*************************************************
PART II ---

So I am led to the the Great Oz' (aka Dr. Jeffrey Isaacs
) office. (And for the record, AGAIN, I am the youngest and HEALTHIEST looking individual -- and that includes patients and their care-takers -- in the bus-station sized waiting room.)

I was led into an exam room so the nurse could take vitals and prelim info. I was then led to the inner sanctum - the Great Oz' office. I found it quirky that the nurse kept insisting that I place myself in this uncomfortable looking armchair perpendicular from Oz' chair -- the one "he always sits in speaking with patients. I sat on the couch.

The second faux pas is that they left me in his office unattended far too long. Curiosity is an unshakable vice of mine. I take note of the vanity wall; the pink-ribbon "awards"; that his medical training took place in South Africa; and that from the few pictures the guy is the quintessential middle-aged++, white-haired, white male, white-cloaked physician. Oz does not disappoint. He blusters in, all six feet-tw0 of him with blazing white hair, ruddy-lined faced and an XXL white doctor's frock with his name embroidered in blue under his right lapel.

The discussion is more than interesting. Some tidbits better than others. That which I found medically useful going forward was:

1. Ultrasound is the best diagnostic tool to identify ILC (Invasive Lobular Carcinoma).
2. I may be "surgically" cured at this point, but the biology of the cancer still exists within me.
3. That ILC has a "long natural history for metastasizing" even after the surgical "cure."
4. ILC is indolent, i.e., that it is prone to late relapses (5 / 10 / 15 years) after the primary tumor is found and removed. And that this is with or without adjuvant treatment.

What I found empirically useful in making my determination not to return to the Great Oz was the heart-to-heart that he and I had about the next step, i.e., adjuvant treatment:

Oz: Chemo is for the "unknown" -- to address the biology of the cancer that still exists within you.

TC: What can you tell about my individualistic "unknown" factors?

Oz:
Your "unknown" is the specific biology of the cancer that still exists within you.

TC: Deja vu? And how do we know that the cancer still exists within me? I had a radical mastectomy - nothing was left.

OZ: We don't, that is the "unknown." You must think of chemotherapy as "buying insurance." You buy it "just in case" you might need it down the road, not because you are certain that you need it.

TC: Ah. Can we speak about the "knowns"?

OZ: What "knowns" are you referring to?

TC: Well, we know that chemo has side-effects, correct? With the drugs that you are proposing (Taxotere* and Cytoxan) is that a certainty?

OZ: That is absolutely correct.

TC:
We have the results of my Oncotype DX - the "RS" score says I have only a 4% margin of efficacy if I opt for chemo, correct?

OZ: If the biology of your tumor was taken into consideration with the Oncotype, yes! (Both Oz and I later independently reconfirmed the results, directly with the pathologist at the Oncotype lab.)

TC: So the choice I am presented with is
100% certainty of side effects with 4% margin of efficacy, correct? And with this "known" you are recommending chemo?

OZ: That is absolutely correct. And, yes, I am!

TC: I am not a statistician, mathematician, or even an economist -- but that does not sound statistically sound nor a good return on my "insurance" investment, to me?

(This is where my "Aha" moment with Oz hits...)

OZ: I suppose it comes down to how much you value your life. Yes, 4% is small but a real benefit. The 4% is your only window of opportunity here to fight the "unknown." If you have any desire to be around to see your children grow and be a grandmother, then 4% is what you are dealing with.

TC: Excuse me! That sounds like a very twisted ultimatum. I value the quality of my life -- and those around me stuck with me and this disease. I am not one for quantity for the sake of quantity! What about the plethora of research that is ongoing?

OZ:
You must understand we have hit a wall with adjuvant therapies. Yes there are millions of dollars raised and spent each year on research -- but it gets us nowhere. You only have one shot at this. This is what we have to offer you, and you have to do something. If we were in Sweden it would be a different story, but we are not. Let's examine you shall we?

One would think I would have walked out at this juncture. But I didn't. It is not because I had bought into his ultimatum. It was just that curious vice gene of mine again. I felt like I was witnessing a multi-car pile up, train crash, or airplane catastrophe. I couldn't walk away. . .

What more did I learn? Well, the icing on the morning was witnessing
Oz verbally tear into his nurse for not getting his exam-room printer working; Oz' decree that I had a bulky uterus and needed to have a pelvic ultrasound done asap; and his tossing me (no kidding -- he tossed) an unsolicited prescription for Tamoxifen. . . .

TC: I would like to discuss my concerns with taking Tamoxifen. I am not comfortable with this script.

OZ: EVERYTHING has side effects. Just take it and let me know by the end of October if you are going to follow my recommendation for chemo.

I left the
Great OZ, standing behind his "big voice" screen turning his control wheels. I was done with the Yellow Brick Road. I learned that I much prefer rabbit holes.


Post Script: I called the radiologist who read the PetScan and asked him to look at my results again, particularly the uterus. He did and amended his report. I went to my GYN and shared Oz' concern and the amended PetScan report. All normal.

----------------------------------
* Taxotere:

The most common severe side effects are low white–blood-cell count, anemia, fatigue, diarrhea, and mouth and throat irritation. Low white–blood-cell count can lead to life-threatening infections. The earliest sign of infection may be fever.

Other common side effects from Taxotere® include nausea, vomiting, hair loss, rash, infusion-site reactions, odd sensations (such as numbness, tingling, or burning) or weakness in the hands and feet, nail changes, muscle and/or bone pain, or excessive tearing.